5 AI Stocks on ASX – BRN, LVT, APX, BTH, ALC

The Artificial Intelligence (AI), or machine learning stocks are in great demand in recent years, as the businesses find it to be an innovative technology, to be applied in multiple fields like improvement of operations, in sales, employee engagement or cost management etc. On a day-to-day basis, millions of consumers are interacting with AI directly or indirectly either through virtual assistants, facial-recognition technology, mapping applications and various other software. It was projected that the annual global revenue for artificial intelligence products and services is expected to post the growth from approximately $644 million in 2016 to $36.8 billion by 2025.

BrainChip Holdings Ltd (ASX: BRN)

Update by BRN for 2019 Year End:

BrainChip Holdings Ltd (ASX: BRN) formerly Aziana Limited, is only one pure player in Artificial Intelligence (AI) segment that is listed on the ASX, gave the update for 2019-year end. In the update, the company informed the completion of Akida logic and layout designs. Design-for-Test (DFT) is projected to get completed and wafer fabrication is expected to commence at Taiwan Semiconductor Manufacturing Company (TSMC) in January 2020.

Further, BRN has signed definitive agreement with Socionext for the development and manufacturing of Akida. Moreover, by the end of September 2019, it had generated cash of US$9.54M. Akida Intellectual Property licensing has good gross margin and operating margin and after getting it is expected to add support for the company’s cash requirements in 2020. BRN will also be opening two Innovation Centers in 2020, first in Western Australia & the other in China.

On 6 January 2020, BRN stock was trading at $0.044, slipping by 2.222 percent (at AEDT 3:41 PM).

LiveTiles Ltd (ASX: LVT)

Substantial Increase in ARR in 2 Years:

LiveTiles Ltd (ASX: LVT) is a leading IT company that provides AI software for the commercial, government, and education markets. The company has recently completed the acquisition of CYCL AG, which is a leading intelligent intranet software company in Switzerland (Europe), for the maximum total consideration price of CHF21.9m ($32.2m). Therefore, the company has issued 42,605,922 shares as part of the upfront consideration for this acquisition.

Moreover, for the September quarter, the company has reported 131% rise in the annualised recurring revenue (ARR) compared to the same quarter last year, to total of $42.9 million. This has been also an increase from $40.1 million as at 30 June 2019. LVT has grown 10x in two years. The company also posted 252% record increase in the cash receipts to $8.5 million. The company has a target to organically grow ARR to approximately $100m by 30 June 2021. Further, LVT is targeting approximately ~$13 billion addressable market of ~300k potential customers.

Rapid Growth of Annualised recurring revenue ($m), Source: Company’s Report

On 6 January 2020, LVT stock was trading at $0.280, rising by 1.818 percent (at AEDT 3:49 PM).

Appen Ltd (ASX: APX)

Raised the underlying EBITDA guidance for full year 2019:

Appen Ltd (ASX: APX), a leading player in AI sector, collects and compiles image, text, speech, audio, and video data to be used for building and improving the artificial intelligence (AI) systems at some of the world’s biggest tech companies.

APX has raised the guidance for full year 2019 and now projects full year 2019 underlying EBITDA, ending December 31 2019 to be in the range of $96M to $99M compared to the previous guidance for underlying EBITDA to be at the upper end of $85M - $90M. The company has raised the forecast for FY 19 on the back of the increases in monthly relevance revenues and margins, mainly from the company’s existing projects and existing customers. Further, the company has reconfirmed the acquisition of Figure Eight and 2019 ARR guidance, expected to be in the range of $30M - $35M (at A$1=US$0.74).

On 6 January 2020, APX stock was trading at $22.190, falling by 1.51 percent (at AEDT 3:56 PM).

Bigtincan Holdings Ltd (ASX: BTH)

Secured the contract of total value of $2.8m for three and a half year:

Bigtincan Holdings Ltd (ASX: BTH) provides sales enablement platform powered by AI that has AI-related features to automate the sales cycle. This platform is also sold on a SaaS basis. BTH along with Paris-based multinational chain of personal care and beauty stores, Sephora USA Inc have secured the contract of total value of $2.8m for three and a half year. The contract will make use of Content, Learning, Add-ons and other features, for which the Bigtincan platform is unique meant for key vertical markets.

Moreover, for FY 20, the company expects organic revenue growth to the tune of 30% to 40%. Further, for the first quarter 2020 ending September, the company has posted 56% increase in the cash receipts to $5.3m. Cash payments during the quarter had increased by 25% to $8.5m.

On 6 January 2020, APX stock last traded at $22.180, falling by 1.51 percent compared to its last close.

Alcidion Group Limited (ASX: ALC)

Two contracts signed recently:

Alcidion Group Limited (ASX: ALC) formerly known as Naracoota Resources Limited, uses the machine learning technology for the analysis of clinical data and underpin the medical teams to monitor and detect patient risks, complications and conditions. The company is into the development and licensing of the healthcare software products like Miya, Patientrack and Smartpage, etc. The company has inked the contract for approximately $1.9 million over 6 years with Dartford and Gravesham NHS Trust, UK for the implementation of the OPENeP Electronic Prescribing and Medications Administration system. Moreover, the company has signed a contract with Taunton and Somerset NHS Foundation Trust for the $500K over three years for delivery of Patientrack, ALC’s electronic observations and patient assessment solution.

On 6 January 2020, ALC stock last traded at $0.185, falling by 2.632 percent compared to its previous close.

Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.